Transcranial Magnetic Stimulation (TMS): How it works, what to expect, side effects.
Transcranial Magnetic Stimulation (TMS) was developed in 1985, and has been FDA-approved since 2008 as an alternative treatment for depression. TMS is covered by most health insurance plans for those with treatment resistant depression (TRD) which is defined as a patient who has tried 4 or more antidepressant medications and therapy without relief. It can also help people with symptoms of PTSD, panic attacks, suicidal thoughts, social anxiety disorder, seasonal affective disorder, and other mental illnesses.
Stephen Manlove, MD is one of the most entrepreneurial psychiatrists in the upper Midwest. Dr. Manlove graduated from the University of Minnesota Medical School and completed residencies in Psychiatry and Internal Medicine through the University of Virginia Medical School. He holds multiple board certifications in psychiatry/neurology, internal medicine and forensic psychiatry. This deep understanding of medicine gives him a unique ability to practice truly holistic psychiatry—fusing lifestyle changes and brain health best practices with genetic testing and a detailed laboratory workup to develop a personalized plan for each patient. As an early adopter of transcranial magnetic stimulation (TMS) and ketamine/Spravato, he and the Manlove Brain + Body team have helped thousands of patients suffering from treatment resistant depression, anxiety and PTSD.
